A J Silman

5.4k total citations
100 papers, 3.7k citations indexed

About

A J Silman is a scholar working on Rheumatology, Surgery and Epidemiology. According to data from OpenAlex, A J Silman has authored 100 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 15 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in A J Silman's work include Rheumatoid Arthritis Research and Therapies (33 papers), Systemic Lupus Erythematosus Research (26 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). A J Silman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (33 papers), Systemic Lupus Erythematosus Research (26 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). A J Silman collaborates with scholars based in United Kingdom, United States and Germany. A J Silman's co-authors include John Schollum, Gary J. Macfarlane, Peter Croft, Alan S. Rigby, Deborah Symmons, Wendy Thomson, Mark Lunt, Terence W O’Neill, Alex J. MacGregor and P Croft and has published in prestigious journals such as American Journal of Epidemiology, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

A J Silman

99 papers receiving 3.6k citations

Peers

A J Silman
Comparison fields: 5 of 119
  • Rheumatology 1.4k
  • Pharmacology 781
  • Psychiatry and Mental health 684
  • Surgery 530
  • Immunology 462
Replace N. Hajjaj‐Hassouni with:
N. Hajjaj‐Hassouni Morocco
Björn Svensson Sweden
H A Smythe Canada
Hanne Dagfinrud Norway
Johannes W. G. Jacobs Netherlands
Jan Tore Gran Norway
Mahmoud Abu‐Shakra Israel
Simon Carette Canada
Alessandro Ciapetti Italy
J F Fries United States
N. Hajjaj‐Hassouni Morocco View profile →
Citations per field, relative to A J Silman
A J Silman · 1×
Citations per year, relative to A J Silman
A J Silman · 1×

Countries citing papers authored by A J Silman

Since Specialization
Citations

This map shows the geographic impact of A J Silman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A J Silman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A J Silman more than expected).

Fields of papers citing papers by A J Silman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A J Silman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A J Silman. The network helps show where A J Silman may publish in the future.

Co-authorship network of co-authors of A J Silman

This figure shows the co-authorship network connecting the top 25 collaborators of A J Silman. A scholar is included among the top collaborators of A J Silman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A J Silman. A J Silman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Influence of anti-tnf therapy and previous malignancy on cancer incidence in patients with Rheumatoid Arthritis (RA): Results from the BSR biologics register (BSRBR)
11
2
Can we predict the outcome of methotrexate treatment in inflammatory polyarthritis using clinical variables
1
3
Pregnancy experience in women with rheumatic diseases exposed to biologic agents: Results from the BSR biologics register
6
4
Increasing age at symptom onset is strongly associated with worse radiologic damage both at presentation and follow-up in an inception cohort of patients with inflammatory polyarthritis
1
5
All cause mortality is not increased following the use of anti-TNF agents in patients with rheumatoid arthritis: Results from a nationwide prospective study
1
6
Serious infection rates in patients receiving biologic therapy in the United Kingdom: Results from the BSR biologics register (BSRBR)
7
7
Relationship between change in skin sclerosis and outcome in diffuse cutaneous systemic sclerosis: Application of a linear latent trajectory model.
2
8
Should infection still be considered as the most likely triggering factor for rheumatoid arthritis? (Reprinted from The Journal of Rheumatology, vol 30, pg 425-429, 2003)
2
9
LOW INTAKE OF VITAMIN C IS ASSOCIATED WITH AN INCREASED RISK OF INFLAMMATORY POLYARTHRITIS
4
10
Baseline CRP is a major predictor of cardiovascular mortality in inflammatory polyarthritis: Results from a population-based inception cohort.
2
11
COMBINATION OF PAIN DRAWING AND SELF-REPORT SHOULD BE USED FOR ASCERTAINING HIP PAIN IN POPULATION SURVEYS
2
12
Early disease modifying treatment limits the severity of radiological erosions in inflammatory polyarthritis
2
13
A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis.
2
14
INFLUENCE OF PREVIOUS PAIN EXPERIENCE ON THE EPISODE INCIDENCE OF LOW-BACK-PAIN
5
15
Low prevalence of rheumatoid arthritis in the urbanized Chinese of Hong Kong.
56
16
THE EUROPEAN-PROSPECTIVE-OSTEOPOROSIS-STUDY (EPOS)
1
17
CONCORDANCE RATES FOR RHEUMATOID-ARTHRITIS IN TWINS - RESULTS OF A NATIONWIDE STUDY
5
18
MODIFICATION OF ARA CLASSIFICATION CRITERIA FOR RHEUMATOID-ARTHRITIS FOR USE IN POPULATION SURVEYS
4
19
THE INCIDENCE OF RHEUMATOID-ARTHRITIS IN NORFOLK, ENGLAND
1
20
Absence of an association between HLA-DRB1(*)04 and rheumatoid arthritis in newly diagnosed cases of RA in a population study
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026